ROBIN L. SMITH, M.D.

Corporate Board Profile

Tech Score: 0/100

Emmaus Life Sciences, Inc.

Filing Date	Source Excerpt
2016-10-06	Dr. Robin L. Smith is a global thought leader in the regenerative medicine industry... She received her M.D. from Yale University and an M.B.A. from the Wharton School of Business.
2017-07-27	Dr. Robin L. Smith is a global thought leader in the regenerative medicine industry... She received her M.D. from Yale University and an M.B.A. from the Wharton School of Business.
2018-03-01	Dr. Robin L. Smith is a global thought leader in the regenerative medicine industry... She received her M.D. from Yale University and an M.B.A. from the Wharton School of Business.

LISATA THERAPEUTICS, INC.

Filing Date	Source Excerpt
2012-09-07	Since 2006, Dr. Smith has also served as Chief Executive Officer and Chairman of the Board. Dr. Robin L. Smith became the Chief Executive Officer and Chairman of the Board of NeoStem effective June 2, 2006. The Board of Directors concluded that Dr. Smith should continue serving as a director based upon her expertise in business development and medicine, including her extensive and diversified experience serving in executive and board capacities in medical enterprises and healthcare-based entities, and her leadership of the Company over the past six years.
2013-08-30	Dr. Robin L. Smith became the Chief Executive Officer and Chairman of the Board of NeoStem effective June 2, 2006... Dr. Smith's expertise in business development and medicine includes her extensive and diversified experience... Since 2006, she has served as chairman and CEO of NeoStem... The Board of Directors has determined that Dr. Smith is CEO and Chairman of the Board... The Summary Compensation Table shows total compensation of $1,643,403 for 2012.

Filing Date

Source Excerpt

2012-09-07

Since 2006, Dr. Smith has also served as Chief Executive Officer and Chairman of the Board. Dr. Robin L. Smith became the Chief Executive Officer and Chairman of the Board of NeoStem effective June 2, 2006. The Board of Directors concluded that Dr. Smith should continue serving as a director based upon her expertise in business development and medicine, including her extensive and diversified experience serving in executive and board capacities in medical enterprises and healthcare-based entities, and her leadership of the Company over the past six years.

2013-08-30

Dr. Robin L. Smith became the Chief Executive Officer and Chairman of the Board of NeoStem effective June 2, 2006... Dr. Smith's expertise in business development and medicine includes her extensive and diversified experience... Since 2006, she has served as chairman and CEO of NeoStem... The Board of Directors has determined that Dr. Smith is CEO and Chairman of the Board... The Summary Compensation Table shows total compensation of $1,643,403 for 2012.

Data sourced from SEC filings. Last updated: 2025-08-30